Journal
CELL REPORTS MEDICINE
Volume 4, Issue 1, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.xcrm.2022.100906
Keywords
-
Categories
Ask authors/readers for more resources
Goodwin et al. found that a single 25 mg dose of psilocybin has short-term antidepressant effects in medication-resistant depression. Unanswered questions include the relationship between psychedelic effects and antidepressant benefits, the use of drug blood levels as a guide to dosage, and the potential risk of suicide associated with psilocybin.
Goodwin et al.(1) report a single 25 mg dose of psilocybin has an antidepressant effect short-term in medication-resistant depression. Unanswered questions include drug blood level as a guide to dose, psychedelic effects relationship to antidepressant benefit, and potential suicide risk of psilocybin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available